Salicylamide
This is an old revision of this page, as edited by DMacks (talk | contribs) at 21:06, 19 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
MedlinePlus | a681004 |
ATC code | |
Pharmacokinetic data | |
Excretion | Renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.554 |
Chemical and physical data | |
Formula | C7H7NO2 |
Molar mass | 137.138 g·mol−1 |
3D model (JSmol) | |
Density | 1.33 g/cm3 |
Solubility in water | Soluble in hot water, ether, alcohol, and chloroform. mg/mL (20 °C) |
| |
| |
(verify) |
Salicylamide (o-hydroxybenzamide or amide of salicyl) is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin.[1] Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedy PainAid. It was also an ingredient in the over-the-counter pain remedy BC Powder but was removed from the formulation in 2009. It was used in later formulations of Vincent's powders in Australia as a substitute for phenacetin.
Derivatives
Derivatives of salicylamide include, ethenzamide, Eupirone, labetalol, medroxalol, lopirin, otilonium, oxyclozanide, salicylanilide, niclosamide, and raclopride.
See also
References
- ^ "Salicylamide". Dictionary.com. Merriam-Webster's Medical Dictionary. Merriam-Webster, Inc. Retrieved December 31, 2006.
External links
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
|
Receptor (ligands) |
| ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||